A
Aptevo Therapeutics (APVO)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Aptevo Therapeutics (APVO)
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing novel immunotherapy candidates for the treatment of different forms of cancer. It has developed two versatile and enabling platform technologies for ratio... Read more
- USD4.50
- USD5.18
- USD4.40
- USD658.60
- -62.40%
- 134.83k
- 404.24k
- 2M
- 4.30
- -99.10%
Stock News
1 hour ago
Jeep reveals new Cherokee SUV, confirms hybrid model
CNBC
1 hour ago
Pharma, chips, other sectors look set to get hit with new tariffs soon, even as a court blocks other Trump levies
MarketWatch
2 hours ago
Paramount cut to Neutral at Citi
Yahoo
2 hours ago
Jim Cramer says a rare dip in our newest stock may be a buy for new investors
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
